Results

Total Results: 4,518 records

Showing results for "question".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - True False Practice Question 1 (1 of 2) Practice Question 1 (1 of 2) Explanation for Question 1: … Practice Question 2 (1 of 2) Practice Question 2 (1 of 2) Explanation for Question 2: The correct … Practice Question 3 (1 of 2) Practice Question 3 (1 of 2) Explanation for Question 3: The correct … Practice Question 3 (2 of 2) Practice Question 3 (2 of 2) When evaluating a medical test with no … True False Practice Question 4 (1 of 2) Practice Question 4 (1 of 2) Explanation for Question 4:
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - Key Question 1. … Key Question 2. … Key Question 3. … Key Question 4. … Key Question 5.
  3. Decision Modeling (ppt file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
    June 01, 2012 - True False Practice Question 1 (1 of 2) Practice Question 1 (1 of 2) Explanation for Question 1: … True False Practice Question 2 (1 of 2) Practice Question 2 (1 of 2) Explanation for Question 2: … 3 (1 of 2) Practice Question 3 (1 of 2) Explanation for Question 3: The correct answer is b. … Practice Question 3 (2 of 2) Practice Question 3 (2 of 2) Test performance (e.g., sensitivity and … True False Practice Question 4 (1 of 2) Practice Question 4 (1 of 2) Explanation for Question
  4. Decision Modeling (ppt file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
    June 01, 2012 - True False Practice Question 1 (1 of 2) Practice Question 1 (1 of 2) Explanation for Question 1: … True False Practice Question 2 (1 of 2) Practice Question 2 (1 of 2) Explanation for Question 2: … 3 (1 of 2) Practice Question 3 (1 of 2) Explanation for Question 3: The correct answer is b. … Practice Question 3 (2 of 2) Practice Question 3 (2 of 2) Test performance (e.g., sensitivity and … True False Practice Question 4 (1 of 2) Practice Question 4 (1 of 2) Explanation for Question
  5. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - Key Question 2. How do patient characteristics affect outcomes? … Key Question 3. How do provider and hospital characteristics affect outcomes? … Key Question 4. How do tumor characteristics affect outcomes? … , conclusion, comments Key Question 1. … evidence Summary, conclusion, comments Key Question 4.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
    February 01, 2012 - Key Question 1. Clinical Utility. … of testing for Key Question 5. … Two studies for Key Question 2 also reported adherence to testing and are discussed with Key Question … Key Question 4. … Key Question 5.
  7. Untitled (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
    December 01, 2015 - Key Question 2. 2a! … Key Question 4. … Key Question 3: Do these harms differ according to patient subgroup characteristics? … Severe rash (5% vs. 1%, RR 4.6, 95% CI 1.6 to 13) Key Question 3. … Key Question 4.
  8. Untitled (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
    December 01, 2015 - Key Question 2. 2a! … Key Question 4. … Key Question 3: Do these harms differ according to patient subgroup characteristics? … Severe rash (5% vs. 1%, RR 4.6, 95% CI 1.6 to 13) Key Question 3. … Key Question 4.
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
    December 11, 2012 - Peer Reviewer #5 Executive Summary Key Question 1a: utility of imaging 1. … Peer Reviewer #5 Executive Summary Key Question 5: Harm of work-up or treatment 1. … Peer Reviewer #5 Introduction Page 32, Line 24-5: Key Question 5: Harm of work-up or treatment 1. … We do not agree that asking the question encourages use. … Question #3 should also include an evaluation of the scrotal (Bianchi) orchiopexy.
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/facilitation-webcast-slides.pptx
    June 13, 2013 - be sharing with you today. 4 Welcome What is a deliberative process and what is a deliberative question … We are saving about a half hour of time for question and answer after the presentation and hope to address … (next slide) 6 The overuse of antibiotics: focus group Question: How can doctors better communicate … (next slide) 7 The overuse of antibiotics: deliberative session Question: should there be more specific … What’s the question?
  11. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - Key Question 2. … Key Question 1. … Key Question 2. … Key Question 3a. … Key Question 3b.
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/ebc-challenge-webinar-transcript.pdf
    June 01, 2014 - Please  note  that you have the  option  to  send your question  to  us privately  by … And so actually our first question is a little bit on a related note. … So I think we’ve got a lot of great  feedback on that particular question. … Any thoughts on that question? Paul.   Yes, this  is Paul.   … That is a great question and of course that would be key.
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
    February 26, 2013 - We have provided explanations below the plots in question. Peer Reviewer 1 Results 5. … Jude Medical Key Question 1 In evaluating this question, it appears the draft report mixes intravascular … Jude Medical Key Question 2 For this question, we were somewhat confused regarding what is meant by … Jude Medical Key Question 4 As stated earlier in our comments, we believe a distinction should be … Jude Medical Key Question 5 In evaluating this question, we were confused in terms of what specifically
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
    April 01, 2013 - Key Question 1: 1a. … Key Question 2: 2a. … Key Question 4: 4. … Key Question 1. 1a. … Key Question 4. 4.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
    July 21, 2014 - Based on additional input from a Technical Expert Panel (see section X below), the EPC removed a question … Key Question 4: For patients with high risk non-muscle-invasive bladder cancer treated with TURBT, what … Key Question 5: In surveillance of patients treated for non-muscle-invasive bladder cancer, what is … Key Question 8: What are the comparative adverse effects of various treatments for non- muscle-invasive … Systematic reviews will be used as primary sources of evidence if they address a key question and are
  16. TND-0775-150722 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0775-150722.pdf
    May 12, 2015 - Staff-Generated PICOs Key Question #1 Population(s): Male and female adults with schizophrenia or … extrapyramidal symptoms); improvements in core illness symptoms (e.g., delusions, hallucinations) Key Question … agitation and aggression); improvements in core illness symptoms (e.g., delusions, hallucinations) Key Question
  17. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
    December 01, 2011 - The strength of evidence ratings for the main outcomes of each Key Question are detailed in Appendix … Summary of findings with strength of evidence, Key Question 3: Comparative efficacy and effectiveness … Summary of findings with strength of evidence, Key Question 3: Comparative efficacy and effectiveness … Summary of findings with strength of evidence, Key Question 3: Comparative efficacy and effectiveness … Summary of findings with strength of evidence, Key Question 4b: Differences in harms, adherence, and
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/deliberative-methods-facilitation-transcript.pdf
    January 11, 2017 - How are they going to answer this question? … Ela did a nice way of just starting out with the question of is the world flat. … I hope that helps answer your question. Have we any further questions Jess? Ms. … ’t be a very open question. … We have another question here.
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/asthma-treatment-future_research.pdf
    September 01, 2012 - High-priority research questions Research Question Number of Votes 1. … However, given that the exposure in question (breathing techniques with or without other intervention … Individual stakeholders could assign a maximum of five stars to any one research question. … at least one star to each question). … 4 had seven stars, and research question 5 had six stars total.
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
    November 27, 2017 - Added Key Question 1a here as suggested. … The section in question is addressing issues related to applicability for Key Question 4. … The section in question is addressing issues related to applicability for Key Question 4. … Evidence on dose comparisons is addressed as a Key Question. … in the methods how the authors aimed to answer this question directly.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: